Summary NAV Details Dividend Detalis Investment Details Ratios Performance Portfolio Analysis In/Out Snapshot

Nippon India Pharma Fund(G)

Summary Fund Name Nippon India Mutual Fund   Scheme Name Nippon India Pharma Fund(G)   AMC Nippon Life India Asset Management Limited   Type Open ended scheme   Category Equity - Sectoral Fund - Pharma & Health Care   Launch Date 05-Jun-04   Fund Manager Sailesh Raj Bhan   Face Value 10   Custodian Deutsche Bank A.G.   Net Assets (Rs. cr) 8357.03   AMC Details Nippon Life India Asset Management Limited 4th Floor, Tower A, Peninsula Business Park, Ganapatrao Kadam Marg, Lower Parel (W) Mumbai - 400 013 Phone : 022-68087000 Fax : 022-68087097 customercare@nipponindiaim.in https://mf.nipponindiaim.com/ Registrar & Transfer Agent Details KFin Technologies Limited 301, Centrium, 3rd Floor, 57, L.B.S. Road Nav Pada, Kurla (West) Mumbai - 400070 022 - 4617 0911 investorsupport.mfs@kfintech.com https://mfs.kfintech.com/ NAV Details NAV Date 17-Sep-25 Max Entry Load % 0.00 NAV [Rs] 518.45 Max Exit Load % 0.00 Buy/Resale Price [Rs] 518.45 52 Week High[Rs] 536.81 (30-Jul-25) Sell/Repurchase Price [Rs] 518.45 52 Week Low[Rs] 451.81 (28-Feb-25) NAV Graph Raw Type Adj Type 1 Month   3 Months   6 Months   1 Year       3 Years     5 Years   SinceInception Dividend Details No Data Found Investment Details Objective The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies Min. Investment (Rs.) 5000 Increm.Investment (Rs.) 1000 Investment Pattern Type Minimum % Maximum % Equity and Equity related Instruments of companies in Pharma Sector 80 100 Equity and Equity related Instruments of companies other than those engaged in Pharma Sector 0 20 Debt & MMI 0 20 Units issued by REITs and InvITs 0 10 SIP Details SIP MIN Investments(Rs.) 100 SIP Incremental Investments(Rs.) 1 SIP Frequency   Daily No.of Investments Cheques Ratios Statistical Ratios Standard Deviation [%] 17.9472 Semi Standard Deviation [%] 0.4703 Beta [%] 0.6411 Sharpe Ratio [%] -0.0977 R-Square [%] 0.5552 Expense Ratio [%] 1.8000 AVG Ratio [%] 0.0001 Other Ratios Jenson Ratio [%] -0.0071 Treynor Ratio [%] -0.0273 Turnover Ratio [%] 0.1400 FAMA Ratio [%] -0.0052 SORTINO Ratio [%] -0.0347 What is Standard Deviation? Standard Deviation is the measure of the deviation in the returns of the portfolio. In Simple Words it tells us how much the return on the fund is deviating from the expected normal return. What is Jenson's Alpha? It measures whether the Scheme is generating excess returns over the normal returns.For example, if there are two mutual funds that both have a 12% return, a rational investor will want the fund that is less risky.If the value is positive, then the portfolio is earning excess returns. In other words, a positive value for Jensen's alpha means a fund manager has 'beat the market' w with his or her stock picking skills. The Higher the value the better the performance. Portfolio Analysis Allocations As on 31-Aug-2025 Fund Size : 8357.03 (Cr.) Bar Chart 3D Bar Chart Pie Chart 3D Pie Chart Pyramid Chart 3D Pyramid Chart Market cap-wise Allocation Style Average Mkt Cap (Rs Cr) 57875.15 Market Capitalization % of Portfolio Large 97.07 Mid 1.02 Small 1.39 Note: Large-Cap = 5000 Crs. and above, Mid-Cap = 2000 Crs. to 5000 Crs. and Small-Cap = less than 2000 Crs. Portfolio Concentration   % Net Assets Top 3 Sectors NA +  -  Top 5 Holdings 37.35 Sun Pharma Inds. 11.94 Divi's Lab 7.34 Cipla 6.09 Lupin 6.09 Apollo Hospital Ent. 5.91 +  -  Top 10 Holdings 56.39 Sun Pharma Inds. 11.94 Divi's Lab 7.34 Cipla 6.09 Lupin 6.09 Apollo Hospital Ent. 5.91 Dr. Reddy's Lab 5.90 Medplus Health Servi 3.65 Vijaya Diagnostic 3.48 Glaxosmithkline Phar 3.04 Gland Pharma 2.96 Holding Details Company Name % Hold   Sun Pharmaceutical Industries Ltd. 11.94   Divi's Laboratories Ltd. 7.34   Cipla Ltd. 6.09   Lupin Ltd. 6.09   Apollo Hospitals Enterprise Ltd. 5.91   Dr. Reddy's Laboratories Ltd. 5.90   Medplus Health Services Ltd. 3.65   Vijaya Diagnostic Centre Ltd. 3.48   Glaxosmithkline Pharmaceuticals Ltd. 3.04   Gland Pharma Ltd. 2.96     Indicates an increase or decrease or no change in holding since last portfolio  Indicates a new holding since last portfolio. Detailed Portfolio Sector Allocation * (as % of equity portfolio) Sector Allocation   Reported Sectors Our Sectors   Chart Type :  Bar Chart 3D Bar Chart Pie Chart 3D Pie Chart *Pertains to the equity investments only. Performance 1 Week   [%] 1 Month   [%] 3 Months   [%] 6 Months   [%] 1 Year   [%] 3 Years   [%] 5 Years   [%] Since INC   [%] Scheme Return 0.62 -0.21 2.21 10.30 -1.03 23.87 18.01 20.37 Category Avg 0.38 0.39 3.82 12.15 -0.01 24.41 17.73 16.22 Category Best -2.03 -3.55 3.11 -0.76 5.06 3.20 11.20 19.46 Category Worst -5.00 -7.10 -3.30 -6.89 -3.39 -6.39 5.83 -4.00 SENSEX 1.56 2.67 1.36 11.49 -0.46 12.01 16.23   NIFTY NA 2.84 1.92 12.54 -0.35 13.05 17.08   *Equity - Returns upto 1 year are absolute and over 1 year are CAGR. *Debt - Returns upto 1 year are annualised and over 1 year are CAGR. What's In / What's Out What's in as on What's out as on Company Name Mkt Value Holdings (Rs.Cr) % No Data Found Company Name Mkt Value Holdings (Rs.Cr) % No Data Found